Effects of molybdate on the sulfation of harmol and α-naphthol

Toxicology

Volumn 127, Issue 1-3, 1998, Pages 121-127

  Boles, James W ^a   Klaassen, Curtis D ^a  

^a Ctr for Environ and Occup Health   (United States)

Author keywords

Naphthol; Harmol; Molybdate

Indexed keywords

1 NAPHTHOL; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; HARMOL; MOLYBDIC ACID; SULFATE; SULFOTRANSFERASE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; BIOTRANSFORMATION; CONJUGATION; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SULFATION; TOXICOKINETICS; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HARMINE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; MALE; MOLYBDENUM; NAPHTHOLS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; SULFOTRANSFERASES; SULFURIC ACID ESTERS;

EID: 0032524372     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(98)00029-8     Document Type: Article

References (24)

1. Bandurski R.S., Wilson L.G., Squires C.L. The mechanism of "active sulfate" formation. J. Am. Chem. Soc. 78:1956;6408-6409.
2. Brzeznicka E.A., Hazelton G.A., Klaassen C.D. Comparison of adenosine 3′-phosphate 5′-phosphosulfate concentrations in tissues from different laboratory animals. Drug Metab. Dispos. 15:1987;133-135.
3. Curtis, C.G., 1982. The origins of intracellular sulphate for conjugation reactions. In: Mulder, G.J., Caldwell, J., Van Kempen, G.M.J., Vonk, R.J. (Eds.), Sulfate Metabolism and Sulfate Conjugation. Taylor and Francis, London, pp. 67-71.
4. Gregus Z., White C., Howell S., Klaassen C.D. Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats. Biochem. Pharmacol. 37:1988;4307-4312.
5. Hjelle J.J., Klaassen C.D. Glucuronidation and biliary excretion of acetaminophen in rats. J. Pharmacol. Exp. Ther. 228:1984;407-413.
6. Hjelle J.J., Hazelton G.A., Klaassen C.D. Acetaminophen decreases adenosine 3′-phosphate 5′-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug Metab. Dispos. 13:1985;35-41.
7. Johnson G.A., Barsuhn K.J., McCall J.M. Sulfation of minoxidil by liver sulfotransferase. Biochem. Pharmacol. 31:1982;2949-2954.
8. Jorritsma J., Meerman J.H., Vonk R.J., Mulder G.J. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat. Xenobiotica. 9:1979;247-252.
9. Kim H.J., Cho J.H., Klaassen C.D. Depletion of hepatic 3′-phosphoadenosine 5′-phosphosulfate (PAPS) and sulfate in rats by xenobiotics that are sulfated. J. Pharmacol. Exp. Ther. 275:1995;654-658.
10. Klaassen C.D., Boles J.W. The importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11:1997;404-418.
11. Krijgsheld K.R., Scholtens E., Mulder G.J. An evaluation of methods to decrease the availability of inorganic sulphate for sulphate conjugation in the rat in vivo. Biochem. Pharmacol. 30:1981;1973-1979.
12. Mason J., Cardin C.J. The competition of molybdate and sulphate ions for a transport system in the ovine small intestine. Res. Vet. Sci. 22:1977;313-315.
13. Meerman J.H., van Doorn A.B., Mulder G.J. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate. Cancer Res. 40:1980;3772-3779.
14. Miller J.A., Miller E.C. Electrophilic sulfuric acid ester metabolites as ultimate carcinogens. Adv. Exp. Med. Biol. 197:1986;583-595.
15. Mulder, G.J., 1981. Sulfation in vivo and in isolated intact cell preparations. In: Mulder, G.J. (Ed.) Sulfation of Drugs and Related Compounds. CRC Press, Boca Raton, FL, pp. 131-185.
16. Mulder G.J., Hagedoorn A.H. UDP glucuronyltransferase and phenolsulfotransferase in vivo and in vitro. Conjugation of harmol and harmalol. Biochem. Pharmacol. 23:1974;2101-2109.
17. Mulder, G.J., Jakoby, W.B., 1990. Sulfation. In: Mulder, G.J. (Ed.), Conjugation Reactions in Drug Metabolism: An Integrated Approach. Taylor and Francis, Philadelphia, PA, pp. 107-161.
18. Oguro T., Gregus Z., Madhu C., Liu L., Klaassen C.D. Molybdate depletes hepatic 3′-phosphoadenosine 5′-phosphosulfate and impairs the sulfation of acetaminophen in rats. J. Pharmacol. Exp. Ther. 270:1994;1145-1151.
19. Oguro T., Madhu C., Liu J., Klaassen C.D. Molybdate impairs glycosaminoglycan sulfation in rat cartilage. Toxicol. Appl. Pharmacol. 136:1996;354-360.
20. Pang K.S., Koster H., Halsema I.C., Scholtens E., Mulder G.J. Aberrant pharmacokinetics of harmol in the perfused rat liver preparation: sulfate and glucuronide conjugations. J. Pharmacol. Exp. Ther. 219:1981;134-140.
21. Pitt M.A. Molybdenum toxicity: interactions between copper, molybdenum and sulphate. Agents Actions. 6:1976;758-769.
22. Rhodes J.C., Houston J.B. Quantification of naphthyl conjugates. Comparison of high-performance liquid chromatography and selective enzyme hydrolysis methods. Xenobiotica. 11:1981;63-70.
23. Robbins P.W., Lipmann F. The enzymatic sequence in the biosynthesis of active sulfate. J. Am. Chem. Soc. 78:1956;6409-6410.
24. Schneider E.G., Durham J.C., Sacktor B. Sodium-dependent transport of inorganic sulfate by rabbit renal brush-border membrane vesicles. Effects of other ions. J. Biol. Chem. 259:1984;14591-14599.